Skip to main content
. 2024 Jan 5;15(2):e02874-23. doi: 10.1128/mbio.02874-23

TABLE 1.

Kinetic and inhibition parameters of the CMY-2 variantsc

CMY-2 variants
Substrate Kinetics parameters Without mutation (CMY-2) V211S (CMY-42) N346Y A114E_N346Y Q120K_N346Y V211S_N346Y A114E_Q120K_
V211S_N346Y (CMY-185)
Nitrocefin
kcat (s−1) 2.4 × 102 ± 0.5 × 102 3.2 × 102 ± 1.02 × 102 61 ± 5 57 ± 10 1.2 × 102 ± 0.9 × 102 85 ± 18 17 ± 9
Km (µM) 17 ± 5 29 ± 12 25 ± 3 16 ± 4 50 ± 40 35 ± 10 39 ± 24
Ki (µM) 1.6 × 102 ± 1.0 × 102 1.3 × 102 ± 0.7 × 102 87 ± 25 68 ± 37 14 ± 12 1.0 × 102 ± 0.5 × 102 18 ± 13
kcat/Km (µM−1 s−1) 14 ± 5 11 ± 5 2.5 ± 0.4 3.6 ± 1.2 2.4 ± 2.5 2.4 ± 0.9 0.4 ± 0.4
Cephalothin
kcat (s−1) 54 ± 0.8 83 ± 7 18 ± 7 3.3 ± 0.1 42 ± 5 9.6 ± 0.2 14 ± 1
Km (µM) 4.1 ± 0.3 7.5 ± 1.1 3.9 ± 0.1 1.4 ± 0.1 18 ± 3 4.4 ± 0.3 19 ± 1
kcat/Km (µM−1 s−1) 13 ± 1 11 ± 2 4.7 ± 1.8 2.3 ± 0.2 2.4 ± 0.5 2.2 ± 0.2 0.8 ± 0.1
Ceftazidime
kcat (s−1) N.D. 1.5 ± 0.2 N.D. N.D. 7.7 × 10−2 ± 0.3 × 10−2 0.3 ± 0.0 0.1 ± 0.0
Km (µM) N.M. 74 ± 10 N.M. N.M. 5.3 ± 0.5 37 ± 2 2.2 ± 0.3
Ki app (µM) 0.7 ± 0.1 N.M. 0.7 ± 0.2 0.3 ± 0.0 N.M. N.M. N.M.
kcat/Km (µM−1 s−1) N.C. 2.0 × 10−2 ± 0.3 × 10−2 N.C. N.C. 1.5 × 10−2 ± 0.2 × 10−2 9.0 × 10−3 ± 0.7 × 10−3 5.3 × 10−2 ± 0.7 × 10−2
Cefiderocol
kcat (s−1) N.D. 3.4 × 10−2 ± 0.2 × 10−2 N.D. N.D. N.D. 4.9 × 10−2 ± 0.3 × 10−2 6.9 × 10−3 ± 0.4 ×10−3 a
Km (µM) N.M. 68 ± 11 N.M. N.M. N.M. 6.9 ± 1.5 N.M.
Ki app (µM) 8.0 ± 1.3 N.M. 0.7 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 N.M. 0.2 ± 0.0
kcat/Km (µM−1 s−1) N.C. 4.9 × 10−4 ± 0.9 × 10−4 N.C. N.C. N.C. 7.1 × 10−3 ± 1.6 × 10−3 3.0 × 10−2 ± 0.2 × 10−2 b
Avibactam
Ki app (µM) 6.3 × 10−2 ± 1.2 × 10−2 3.4 × 10−2 ± 0.6 × 10−2 41 ± 6 80 ± 9 5.9 × 102 ± 0.2 × 102 14 ± 4 1.3 × 103 ± 0.1 × 103
k2/K (M−1 s−1) 2.8 × 104 ± 0.1 × 104 2.3 × 104 ± 0.1 × 104 59 ± 6 41 ± 0.4 32 ± 0.4 66 ± 6 7.4 ± 0.3
k−2 (s−1) 1.2 × 10−4 ± 0.2 × 10−4 1.5 × 10−4 ± 0.2 × 10−4 1 × 10−5 ± 16 × 10−5 1.1 × 10−4 ± 0.0 × 10−4 2.0 × 10−3 ± 0.1 × 10−3 4.4 × 10−4 ± 2.1 × 10−4 7.0 × 10−4 ± 0.5 × 10−4
koff (s−1) 7.3 × 10−5 ± 0.0 × 10−5 6.0 × 10−5 ± 0.0 × 10−5 2.6 × 10−6 ± 0.0 × 10−6 9.0 × 10−7 ± 0.0 × 10−7 4.0 × 10−6 ± 0.0 ×10−6 2.4 × 10−6 ± 0.0 × 10−6 4.8 × 10−7 ± 0.0 × 10−7
a

Due to the small Km value of CMY-185 for cefiderocol, the kcat value was determined with the measured velocities at the steady state (cefiderocol concentration range: 3.7–59.4 µM) and the Ki app value assumed to Km.

b

The kcat/Ki app value is shown.

c

The values are the mean ± standard error of three independent measurements. N.M. = not measured; N.D. = not detected; N.C. = not calculated.